Acknowledgement
Supported by : Ministry of Health and Welfare
References
- Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004;351:1860-1873. https://doi.org/10.1056/NEJMra041875
- Rajkumar SV, Gertz MA, Kyle RA. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 1998;82:1501-1505. https://doi.org/10.1002/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8
- Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985;6:737-743. https://doi.org/10.1016/S0735-1097(85)80475-7
- International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-757. https://doi.org/10.1046/j.1365-2141.2003.04355.x
- Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-224. https://doi.org/10.1038/leu.2008.307
- Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. https://doi.org/10.1016/j.echo.2005.10.005
- Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133. https://doi.org/10.1016/j.echo.2008.11.023
- Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713. https://doi.org/10.1016/j.echo.2010.05.010
- Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-2879. https://doi.org/10.1002/cncr.11407
- Russell JA, Powles RL. The relationship between serum viscosity, hypervolaemia and clinical manifestations associated with circulating paraprotein. Br J Haematol 1978;39:163-175. https://doi.org/10.1111/j.1365-2141.1978.tb01086.x
- Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 2003;29:467-471. https://doi.org/10.1055/s-2003-44554
- Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006;47:2357-2363. https://doi.org/10.1016/j.jacc.2006.02.048
- Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-1794. https://doi.org/10.1161/01.CIR.102.15.1788
- Firstenberg MS, Levine BD, Garcia MJ, et al. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol 2000;36:1664-1669. https://doi.org/10.1016/S0735-1097(00)00909-8
- Somer T. Rheology of paraproteinaemias and the plasma hyperviscosity syndrome. Baillieres Clin Haematol 1987;1:695-723. https://doi.org/10.1016/S0950-3536(87)80021-5
- Carr ME Jr, Zekert SL. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am J Physiol 1994;266(3 Pt 2):H1195-H1201.
- Morsdorf S, Jung F, Seyfert UT, Mrowietz C, Pindur G, Wenzel E. Haemostatical and rheological aspects of dysfibrinogenemia. Clin Hemorheol Microcirc 1997;17:13-19.
- Baskurt OK, Yalcin O, Meiselman HJ. Hemorheology and vascular control mechanisms. Clin Hemorheol Microcirc 2004;30:169-178.
- Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003;29:435-450. https://doi.org/10.1055/s-2003-44551
- Liao R, Jain M, Teller P, et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 2001;104:1594-1597. https://doi.org/10.1161/circ.104.14.1594
- Jimenez-Zepeda VH. Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol 2012;34:347-355. https://doi.org/10.1111/j.1751-553X.2012.01419.x
- Schattner A, Epstein M, Berrebi A, Caspi A. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis. Am J Med Sci 1995;310:256-257.
- Garton MJ, Walton S, Ewen SW. Systemic lambda lightchain deposition presenting with predominant cardiac involvement. Postgrad Med J 1993;69:588-591. https://doi.org/10.1136/pgmj.69.813.588
- Shustik C, Bergsagel DE, Pruzanski W. Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood 1976;48:41-51.
- Ozsan GH, Dispenzieri A. Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias. Expert Rev Clin Immunol 2011;7:65-73. https://doi.org/10.1586/eci.10.80
- Wan SH, Vogel MW, Chen HH. Pre-clinical diastolic dysfunction. J Am Coll Cardiol 2014;63:407-416. https://doi.org/10.1016/j.jacc.2013.10.063
Cited by
- Capillary electrophoresis analysis of N‐glycosylation changes of serum paraproteins in multiple myeloma vol.38, pp.17, 2017, https://doi.org/10.1002/elps.201700006